Not available
Quote | Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)
Last: | $6.49 |
---|---|
Change Percent: | 0.0% |
Open: | $6.11 |
Close: | $6.49 |
High: | $6.575 |
Low: | $6.04 |
Volume: | 1,290,832 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
News | Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)
2024-06-20 13:00:43 ET Summary Ironwood Pharmaceuticals, Inc. data from the phase 2 proof-of-concept study, using CNP-104 for the treatment of patients with primary biliary cholangitis, expected in Q3 of 2024. The global primary biliary cholangitis therapeutics market size is proj...
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City. A live webcast of I...
Message Board Posts | Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $IRWD News Article - Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2021 | whytestocks | investorshangout | 02/03/2022 8:05:50 PM |
whytestocks: $IRWD News Article - Ironwood Pharmaceuticals Announces That The American Journal of Ga | whytestocks | investorshangout | 06/16/2021 8:50:49 PM |
Hearing rumblings of $IRWD this week. Anyone else? | BabySealHugger | investorshub | 01/23/2021 2:36:10 AM |
Just In: $IRWD Ironwood Pharmaceuticals Inc ($IRWD) Q3 | whytestocks | investorshub | 11/07/2020 2:30:18 PM |
Just In: $IRWD Ironwood to Discontinue IW-3718 Development | whytestocks | investorshub | 09/30/2020 3:15:24 AM |
News, Short Squeeze, Breakout and More Instantly...
Ironwood Pharmaceuticals Inc. Company Name:
IRWD Stock Symbol:
NASDAQ Market:
Ironwood Pharmaceuticals Inc. Website:
Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that Sravan Emany, Chief Financial Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 9:00 a.m. ET at the Marriott Marquis in New York City. A live webcast of I...
2024-05-22 07:30:10 ET Wells Fargo analyst issues OVERWEIGHT recommendation for IRWD on May 22, 2024 05:13AM ET. The previous analyst recommendation was Overweight. IRWD was trading at $6.78 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-22 07:00:07 ET Mohit Bansal from Wells Fargo issued a price target of $14.00 for IRWD on 2024-05-22 05:13:00. The adjusted price target was set to $14.00. At the time of the announcement, IRWD was trading at $6.78. The overall price target consensus is at $16.00 ...